Trials / Recruiting
RecruitingNCT05962424
HNC: Human Neural Circuits Electrophysiology During Cognition
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Detailed description
The goal of this proposed research is to record the effects of ketamine on brain activity to understand the changes that occur during antidepressant therapy and the side effect of dissociation. This research is designed to probe altered cognitive states associated with dissociation, depression, and other neuropsychiatric conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine Hydrochloride | Ketamine is an FDA-approved dissociative anesthetic. |
Timeline
- Start date
- 2023-10-05
- Primary completion
- 2030-09-01
- Completion
- 2030-09-01
- First posted
- 2023-07-27
- Last updated
- 2025-08-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05962424. Inclusion in this directory is not an endorsement.